Literature DB >> 2995844

Leukotrienes C4, D4 and E4 cause widespread and extensive plasma extravasation in the guinea pig.

X Y Hua, S E Dahlén, J M Lundberg, S Hammarström, P Hedqvist.   

Abstract

Intravenous injection of leukotriene C4 (1 nmol X kg-1) caused substantial plasma exudation in anesthetized guinea pigs, as evidenced by marked hemoconcentration 15% in 5 min) and significant extravasation of Evans blue. Fluorometric quantitation of Evans blue content in 38 selected tissues documented that leukotriene C4 caused significant plasma extravasation throughout the body, except for the brain, stomach, duodenum, colon and gonads. In particular, the respiratory and the uro-genital tracts, but also the conjunctiva, the esophagus, the bile ducts and the umbilical ligaments, were very sensitive to the edema-promoting effect of leukotriene C4. Intravenous injection of leukotriene D4 (1 nmol- X kg-1) or E4 (5 nmol X kg-1) evoked plasma extravasation with a distribution and magnitude that was similar to that induced by leukotriene C4. It is concluded that the three major constituents of slow reacting substance of anaphylaxis (SRS-A), leukotrienes C4, D4 and E4, cause a generalized and extensive plasma exudation that is consistent with the proposal that these leukotrienes are important mediators of inflammation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2995844     DOI: 10.1007/bf00499906

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  18 in total

1.  The effect of leukotrienes C4 and D4 on the microvasculature of guinea-pig skin.

Authors:  M J Peck; P J Piper; T J Williams
Journal:  Prostaglandins       Date:  1981-02

2.  Leukotriene C4 affects pulmonary and cardiovascular dynamics in monkey.

Authors:  G Smedegård; P Hedqvist; S E Dahlén; B Revenäs; S Hammarström; B Samuelsson
Journal:  Nature       Date:  1982-01-28       Impact factor: 49.962

3.  Rapid in vivo metabolism of leukotriene C3 in the monkey Macaca irus.

Authors:  S Hammarström; K Bernström; L Orning; S E Dahlén; P Hedqvist
Journal:  Biochem Biophys Res Commun       Date:  1981-08-31       Impact factor: 3.575

4.  Pulmonary effects of leukotrienes.

Authors:  S E Dahlén
Journal:  Acta Physiol Scand Suppl       Date:  1983

5.  Vascular protein linkage in various tissue induced by substance P, capsaicin, bradykinin, serotonin, histamine and by antigen challenge.

Authors:  A Saria; J M Lundberg; G Skofitsch; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-11       Impact factor: 3.000

6.  Leukotriene C: a slow-reacting substance from murine mastocytoma cells.

Authors:  R C Murphy; S Hammarström; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

7.  A blood-testis barrier restricting passage from blood into rete testis fluid but not into lymph.

Authors:  B P Setchell; J K Voglmayr; G M Waites
Journal:  J Physiol       Date:  1969-01       Impact factor: 5.182

8.  Leukotriene D4: a potent coronary artery vasoconstrictor associated with impaired ventricular contraction.

Authors:  F Michelassi; L Landa; R D Hill; E Lowenstein; W D Watkins; A J Petkau; W M Zapol
Journal:  Science       Date:  1982-08-27       Impact factor: 47.728

9.  Vascular permeability changes and smooth muscle contraction in relation to capsaicin-sensitive substance P afferents in the guinea-pig.

Authors:  J M Lundberg; E Brodin; X Hua; A Saria
Journal:  Acta Physiol Scand       Date:  1984-02

10.  The actions of leukotrienes C4 and D4 on guinea-pig isolated hearts.

Authors:  L G Letts; P J Piper
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

View more
  17 in total

Review 1.  Leukotriene receptors.

Authors:  S E Dahlén
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

2.  Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma.

Authors:  Y Nakamura; M Hoshino; J J Sim; K Ishii; K Hosaka; T Sakamoto
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

3.  Effect of a 5-lipoxygenase inhibitor and leukotriene antagonist (PF 5901) on PAF-induced airway responses in neonatally immunized rabbits.

Authors:  C M Herd; D Donigi-Gale; T S Shoupe; C P Page
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

4.  Synergistic effects of LTB4 and LTD4 on leukocyte emigration into the guinea pig conjunctiva.

Authors:  C S Spada; D F Woodward; S B Hawley; A L Nieves; L S Williams; B J Feldmann
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

5.  Leukotrienes as mediators in ischemia-reperfusion injury in a microcirculation model in the hamster.

Authors:  H A Lehr; A Guhlmann; D Nolte; D Keppler; K Messmer
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

6.  Involvement of cysteinyl leukotrienes in airway smooth muscle cell DNA synthesis after repeated allergen exposure in sensitized Brown Norway rats.

Authors:  M Salmon; D A Walsh; T J Huang; P J Barnes; T B Leonard; D W Hay; K F Chung
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

7.  Effect of prostaglandin E1 on leukotriene C4-induced increases in vascular permeability of hamster cheek pouch.

Authors:  T Yong; W G Mayhan
Journal:  Inflammation       Date:  1992-04       Impact factor: 4.092

Review 8.  Aetiology of running-related gastrointestinal dysfunction. How far is the finishing line?

Authors:  S M Gil; E Yazaki; D F Evans
Journal:  Sports Med       Date:  1998-12       Impact factor: 11.136

9.  High-affinity pan-specific monoclonal antibodies that target cysteinyl leukotrienes and show efficacy in an acute model of colitis.

Authors:  Ashlee N King; Jonathan K Fleming; Stephanie S Knapik; Barbara Visentin; Jonathan M Wojciak; Tom Huxford
Journal:  J Lipid Res       Date:  2017-05-15       Impact factor: 5.922

10.  Role of leukotrienes in leukocyte adhesion following systemic administration of oxidatively modified human low density lipoprotein in hamsters.

Authors:  H A Lehr; C Hübner; B Finckh; S Angermüller; D Nolte; U Beisiegel; A Kohlschütter; K Messmer
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.